Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects
A legfontosabb adatok
- Ki végzi
- Children's National Research Institute
- Hol
- Washington D.C. (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 10 fő, tervezett
- Kezdés
- 2024. jan. 26.
- Várható befejezés
- 2028. aug.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Focused Ultrasound Pallidotomy
- A regiszteradat frissítve
- 2026. június 11.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for children and young adults with dystonia (uncontrolled twisting movements) caused by dyskinetic cerebral palsy. Their doctor has chosen GPi-DBS or pallidotomy, and they have chosen pallidotomy, here done with focused ultrasound.
- Életkor
- 8 to 22 years
- Nem
- All sexes
- A betegség stádiuma
- Secondary dystonia due to cerebral palsy caused by lack of oxygen around birth (perinatal hypoxic injury). Brain areas globus pallidus internus and thalamus must look intact on MRI.
- Korábbi kezelés
- Medicines against dystonia have not helped enough. Dystonia medicines must have been stable for the last 30 days.
- Biomarker vagy leletérték
- Skull Density Ratio (SDR) of 0.40 or more. Head circumference of at least 49cm (19 in).
A részvétel fő kizáró okai
- Primary (for example DYT1) or idiopathic dystonia
- Severe spasticity (Modified Ashworth Scale >3), fixed hemi-dystonia or total loss of head control
- Other severe brain disease, such as brain tumor or neurodegenerative disease
- DBS leads in place, or a condition likely to need MRI in the future
- Pregnancy, breastfeeding, or blood thinners that cannot be stopped around surgery
A regiszter feltételei, szó szerint
Mind a 35 feltétel megnézéseKevesebb
Ki vehet részt
- The treating physician has chosen GPi-DBS or pallidotomy for the treatment of the secondary dystonia caused by cerebral palsy in this patient
- Patient and/or legal representative, if the patient is underaged or not capable to give consent himself, have chosen pallidotomy as treatment
- The consent to participate in the trial of the underaged patient, if he is capable to understand the study requirements, is required
- Age at enrolment 8-22 years
- Diagnosis of secondary dystonia due to cerebral palsy caused by perinatal hypoxic injury
- Anti-dystonic pharmacotherapy insufficient
- Stable anti-dystonic medication over the last 30 days
- Globus pallidus internus (pars posterior) and thalamus (motor part) intact on MRI (not older than 2 years - if possible)
- No fixed severe skeletal deformations with loss of function, which need immediate orthopaedic surgical intervention
- Sufficient compliance of the patient or the legal representative if the patient is underaged or not capable to give consent himself to take part in the study
- Informed consent to take part in the study from patient and/or legal representative if the patient is underaged or not capable to give consent himself
- Patient and/or legal representative if the patient is underaged or not capable to give consent himself, understands the study requirements and the treatment procedures and provides written informed consent before any study-specific tests or procedures are performed
Ki nem vehet részt
- Severe axial hypotonia with total loss of head control (e.g. absence of control at "upper thoracic level" in the SATCo score) (medication effect excluded)
- Fixed severe skeletal contractions with loss of function which require immediate orthopaedic surgical intervention
- Patients with other severe concurrent neurological disease (e. g. brain tumor, neurodegenerative diseases, trauma etc.)
- Any findings in neuropsychological screening assessments that would contraindicate DBS surgery
- Any current drug and / or alcohol abuse
- Any other active implanted device (e.g. Cochlear implant, pacemaker), whether turned on or off, would be allowed provided that they do not interfere with functioning of the device
- Currently on any anticoagulant medications that cannot be discontinued during perioperative period
- Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days; any other trial participation should be approved by the Principal Investigator
- Condition likely to require use of MRI in the future
- Any intracranial abnormality or medical condition that would contraindicate DBS surgery
- Any history of frequent grand-mal seizures without response to anticonvulsive treatment
- A history of neurostimulation intolerance in any area of the body
- Any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints, including any terminal illness with survival <24 months
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the subject or the quality of the data
- Patients with known primary (e.g. DYT1) or idiopathic dystonia
- Fixed hemi-dystonia
- Severe spasticity in knee- and elbow-flexors and -extensors (Modified Ashworth Scale >3)
- The presence of DBS leads due the risks of these ferromagnetic devices in the MRI environment
- A female that is breastfeeding or of childbearing potential with a positive urine pregnancy test or - if a person is sexually active - not using sufficient contraception with a Pearl Index of less than 1% including all forms of hormonal contraception ("antibaby-pill", hormonal plaster, NuvaRing®, Implanon®, hormonal depot injections, contraceptive coil), the tubal ligature (female sterilization). Alternatively, the female of child bearing potential is sexually abstinent
- Subjects who have contraindications to anesthesia, in the judgment of the attending anesthesiologist
- Subjects who are unwilling or unable to undergo general anesthesia
- Minimum head circumference < 49cm
- Skull Density Ratio (SDR) <0.40
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 8 és 22 év között vagy?
Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.
- Children's National HospitalWashington D.C., Egyesült ÁllamokContact: Chima Oluigbo, MDRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
The primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy
A vizsgálat csoportja
- Focused Ultrasound PallidotomyA vizsgált kezelés
Pediatric and young adult patients between ages of 8 and 22 years with pharmaco-resistant secondary dystonia due to dyskinetic cerebral palsy who have Focused Ultrasound Pallidotomy
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Safety and Impact on Quality of Life of Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT06036199: ki vehet részt
- A regiszteradat frissítve
- 2026. június 11.